Sulfonamide inhibitors of matrix metalloproteinases
    2.
    发明授权
    Sulfonamide inhibitors of matrix metalloproteinases 失效
    基质金属蛋白酶的磺酰胺抑制剂

    公开(公告)号:US5977141A

    公开(公告)日:1999-11-02

    申请号:US068726

    申请日:1998-05-13

    摘要: Sulfonamide compounds are described which are inhibitors of matrix metalloproteinases, particularly stromelysin-1 and gelatinase A (72 kD gelatinase). Also described are methods for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumor angiogenesis, arthritis, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes using the compounds.

    摘要翻译: PCT No.PCT / US96 / 16761 Sec。 371日期:1996年5月13日 102(e)日期1996年5月13日PCT提交1996年10月18日PCT公布。 WO97 / 19068 PCT公开号 日期1997年5月8日描述了磺酰胺化合物,其是基质金属蛋白酶抑制剂,特别是溶基质蛋白酶-1和明胶酶A(72kD明胶酶)。 还描述了治疗多发性硬化,动脉粥样硬化斑块破裂,主动脉瘤,心力衰竭,再狭窄,牙周病,角膜溃疡,烧伤,褥疮性溃疡,慢性溃疡或创伤,癌症转移,肿瘤血管生成,关节炎或其它自身免疫的方法 或依赖于使用该化合物的白细胞的组织侵袭的炎性病症。

    Sulfonamide inhibitors of matrix metalloproteinases
    3.
    发明授权
    Sulfonamide inhibitors of matrix metalloproteinases 失效
    基质金属蛋白酶的磺酰胺抑制剂

    公开(公告)号:US06297247B1

    公开(公告)日:2001-10-02

    申请号:US09599306

    申请日:2000-06-22

    IPC分类号: A61K31451

    摘要: Sulfonamide compounds are described which are inhibitors of matrix metalloproteinases, particularly stromelysin-1 and gelatinase A (72 kD gelatinase). Also described are methods for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumor angiogenesis, arthritis, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes using the compounds.

    摘要翻译: 描述了磺酰胺化合物,其是基质金属蛋白酶抑制剂,特别是溶基质蛋白酶-1和明胶酶A(72kD明胶酶)。 还描述了治疗多发性硬化,动脉粥样硬化斑块破裂,主动脉瘤,心力衰竭,再狭窄,牙周病,角膜溃疡,烧伤,褥疮性溃疡,慢性溃疡或创伤,癌症转移,肿瘤血管生成,关节炎或其他自身免疫的方法 或依赖于使用该化合物的白细胞的组织侵袭的炎性病症。

    Sulfonamide inhibitors of matrix metalloproteinases
    4.
    发明授权
    Sulfonamide inhibitors of matrix metalloproteinases 失效
    基质金属蛋白酶的磺酰胺抑制剂

    公开(公告)号:US6153612A

    公开(公告)日:2000-11-28

    申请号:US412707

    申请日:1999-10-05

    摘要: Sulfonamide compounds are described which are inhibitors of matrix metalloproteinases, particularly stromelysin-1 and gelatinase A (72 kD gelatinase). Also described are methods for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumor angiogenesis, arthritis, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes using the compounds.

    摘要翻译: 描述了磺酰胺化合物,其是基质金属蛋白酶抑制剂,特别是溶基质蛋白酶-1和明胶酶A(72kD明胶酶)。 还描述了治疗多发性硬化,动脉粥样硬化斑块破裂,主动脉瘤,心力衰竭,再狭窄,牙周病,角膜溃疡,烧伤,褥疮性溃疡,慢性溃疡或创伤,癌症转移,肿瘤血管生成,关节炎或其他自身免疫的方法 或依赖于使用该化合物的白细胞的组织侵袭的炎性病症。